Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Marchex (MCHX) Research & Development (2016 - 2025)

Marchex (MCHX) has 16 years of Research & Development data on record, last reported at $2.2 million in Q4 2025.

  • On a quarterly basis, Research & Development fell 22.39% to $2.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.7 million, a 21.49% decrease, with the full-year FY2025 number at $9.7 million, down 21.48% from a year prior.
  • Research & Development reached $2.2 million in Q4 2025 per MCHX's latest filing, down from $2.4 million in the prior quarter.
  • Over the last five years, Research & Development for MCHX hit a ceiling of $5.3 million in Q1 2021 and a floor of $2.2 million in Q4 2025.
  • A 5-year average of $3.4 million and a median of $3.2 million in 2024 define the central range for Research & Development.
  • Peak YoY movement for Research & Development: tumbled 45.39% in 2021, then surged 36.03% in 2022.
  • Tracing MCHX's Research & Development over 5 years: stood at $2.8 million in 2021, then soared by 36.03% to $3.8 million in 2022, then dropped by 17.89% to $3.2 million in 2023, then fell by 9.9% to $2.8 million in 2024, then decreased by 22.39% to $2.2 million in 2025.
  • Business Quant data shows Research & Development for MCHX at $2.2 million in Q4 2025, $2.4 million in Q3 2025, and $2.5 million in Q2 2025.